{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T10:34:02Z","timestamp":1775298842887,"version":"3.50.1"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T00:00:00Z","timestamp":1591833600000},"content-version":"am","delay-in-days":346,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.jconrel.2019.05.026","type":"journal-article","created":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T11:17:30Z","timestamp":1558351050000},"page":"149-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Pluronic block copolymers enhance the anti-myeloma activity of proteasome inhibitors"],"prefix":"10.1016","volume":"306","author":[{"given":"Hangting","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armen","family":"Petrosyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia A.","family":"Osna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Appolinaire A.","family":"Olou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daria Y.","family":"Alakhova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pankaj K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander V.","family":"Kabanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Edward A.","family":"Faber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana K.","family":"Bronich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2019.05.026_bb0005","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/leu.2013.313","article-title":"Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients","volume":"28","author":"Kumar","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.jconrel.2019.05.026_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0609.2010.01542.x","article-title":"Emerging therapies for the treatment of relapsed or refractory multiple myeloma","volume":"86","author":"Dimopoulos","year":"2011","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0015","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.transci.2013.07.017","article-title":"Continuous treatment in multiple myeloma: the future?","volume":"49","author":"Vande Broek","year":"2013","journal-title":"Transfus. Apher. Sci."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0020","first-page":"4996","article-title":"Proteasome inhibitor PS-341 inhibits human myeloma cell growth in vivo and prolongs survival in a murine model","volume":"62","author":"LeBlanc","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0025","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1182\/blood-2003-08-2873","article-title":"The bortezomib\/proteasome inhibitor PS-341 and triterpenoid CDDO-Im induce synergistic anti-multiple myeloma (MM) activity and overcome bortezomib resistance","volume":"103","author":"Chauhan","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2019.05.026_bb0030","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1158\/1078-0432.CCR-03-0561","article-title":"Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors","volume":"10","author":"Pei","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0035","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2141.2007.06772.x","article-title":"The histone deacetylase inhibitor, PXD101, potentiates bortezomib-induced anti-multiple myeloma effect by induction of oxidative stress and DNA damage","volume":"139","author":"Feng","year":"2007","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0040","doi-asserted-by":"crossref","first-page":"209","DOI":"10.18632\/oncotarget.246","article-title":"Proteotoxic stress targeted therapy (PSTT): induction of protein misfolding enhances the antitumor effect of the proteasome inhibitor bortezomib","volume":"2","author":"Neznanov","year":"2011","journal-title":"Oncotarget"},{"key":"10.1016\/j.jconrel.2019.05.026_bb0045","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/leu.2014.300","article-title":"Anti-tumor activities of selective HSP90alpha\/beta inhibitor, TAS-116, in combination with bortezomib in multiple myeloma","volume":"29","author":"Suzuki","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.jconrel.2019.05.026_bb0050","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1182\/blood-2013-11-539395","article-title":"Targeting MUC1-C is synergistic with bortezomib in downregulating TIGAR and inducing ROS-mediated myeloma cell death","volume":"123","author":"Yin","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2019.05.026_bb0055","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1021\/bc950093n","article-title":"Hypersensitization of multidrug resistant human ovarian carcinoma cells by pluronic P85 block copolymer","volume":"7","author":"Alakhov","year":"1996","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0060","first-page":"3626","article-title":"Hypersensitizing effect of pluronic L61 on cytotoxic activity, transport, and subcellular distribution of doxorubicin in multiple drug-resistant cells","volume":"56","author":"Venne","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0065","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1054\/bjoc.2001.2165","article-title":"Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: selective energy depletion","volume":"85","author":"Batrakova","year":"2001","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2019.05.026_bb0070","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1023\/A:1026179132599","article-title":"Sensitization of cells overexpressing multidrug-resistant proteins by pluronic P85","volume":"20","author":"Batrakova","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0075","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jconrel.2009.09.026","article-title":"Differential metabolic responses to pluronic in MDR and non-MDR cells: a novel pathway for chemosensitization of drug resistant cancers","volume":"142","author":"Alakhova","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2019.05.026_bb0080","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/bjc.1996.587","article-title":"Anthracycline antibiotics non-covalently incorporated into the block copolymer micelles: in vivo evaluation of anti-cancer activity","volume":"74","author":"Batrakova","year":"1996","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2019.05.026_bb0085","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0927-7765(99)00064-8","article-title":"Block copolymer-based formulation of doxorubicin. From cell screen to clinical trials","volume":"16","author":"Alakhov","year":"1999","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2019.05.026_bb0090","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s10637-010-9399-1","article-title":"A phase 2 study of SP1049C, doxorubicin in P-glycoprotein-targeting pluronics, in patients with advanced adenocarcinoma of the esophagus and gastroesophageal junction","volume":"29","author":"Valle","year":"2011","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.jconrel.2019.05.026_bb0095","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/onc.2008.385","article-title":"Bortezomib overcomes cell-adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myeloma","volume":"28","author":"Noborio-Hatano","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.jconrel.2019.05.026_bb0100","series-title":"Hypoxia","first-page":"95","article-title":"Hypoxia-induced metabolomic alterations in pancreatic cancer cells","author":"Gunda","year":"2018"},{"key":"10.1016\/j.jconrel.2019.05.026_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154416","article-title":"Validation of metabolic alterations in microscale cell culture lysates using hydrophilic interaction liquid chromatography (HILIC)-tandem mass spectrometry-based metabolomics","volume":"11","author":"Gunda","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2019.05.026_bb0110","doi-asserted-by":"crossref","first-page":"13787","DOI":"10.1073\/pnas.1203339109","article-title":"MUC1 mucin stabilizes and activates hypoxia-inducible factor 1 alpha to regulate metabolism in pancreatic cancer","volume":"109","author":"Chaika","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0115","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1124\/jpet.102.043307","article-title":"Optimal structure requirements for pluronic block copolymers in modifying P-glycoprotein drug efflux transporter activity in bovine brain microvessel endothelial cells","volume":"304","author":"Batrakova","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0120","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jconrel.2015.09.007","article-title":"Targeted delivery of platinum-taxane combination therapy in ovarian cancer","volume":"220","author":"Desale","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2019.05.026_bb0125","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1200\/JCO.2007.15.2546","article-title":"Individualizing treatment of patients with myeloma in the era of novel agents","volume":"26","author":"San-Miguel","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0130","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.exphem.2012.10.002","article-title":"Combination chemotherapy increases cytotoxicity of multiple myeloma cells by modification of nuclear factor (NF)-kappaB activity","volume":"41","author":"Salem","year":"2013","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0135","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1182\/blood.V114.22.2878.2878","article-title":"Natural history of multiple myeloma relapsing after therapy with IMiDs and Bortezomib: a multicenter international myeloma working group study","volume":"114","author":"Kumar","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2019.05.026_bb0140","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1158\/1078-0432.CCR-10-1805","article-title":"Treatment options for relapsed and refractory multiple myeloma","volume":"17","author":"Lonial","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0145","first-page":"950","article-title":"Effect of intratumoral injection of carboplatin combined with pluronic P85 or L61 on experimental colorectal carcinoma in rats","volume":"232","author":"Krupka","year":"2007","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.jconrel.2019.05.026_bb0150","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1021\/mp050050g","article-title":"Alteration of genomic responses to doxorubicin and prevention of MDR in breast cancer cells by a polymer excipient: pluronic P85","volume":"3","author":"Batrakova","year":"2006","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0155","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jconrel.2008.07.031","article-title":"Prevention of MDR development in leukemia cells by micelle-forming polymeric surfactant","volume":"131","author":"Sharma","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2019.05.026_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072238","article-title":"Effect of doxorubicin\/pluronic SP1049C on tumorigenicity, aggressiveness, DNA methylation and stem cell markers in murine leukemia","volume":"8","author":"Alakhova","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2019.05.026_bb0165","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/ajh.23387","article-title":"Identification of an ABCB1 (P-glycoprotein)-positive carfilzomib-resistant myeloma subpopulation by the pluripotent stem cell fluorescent dye CDy1","volume":"88","author":"Hawley","year":"2013","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0170","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0022-3565(24)38781-6","article-title":"Pluronic P85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies","volume":"296","author":"Batrakova","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0175","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/156800911794519752","article-title":"Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives","volume":"11","author":"Chen","year":"2011","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.jconrel.2019.05.026_bb0180","doi-asserted-by":"crossref","first-page":"e353","DOI":"10.1038\/cddis.2012.87","article-title":"Synergistic effects of nelfinavir and bortezomib on proteotoxic death of NSCLC and multiple myeloma cells","volume":"3","author":"Kawabata","year":"2012","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0185","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ymeth.2004.10.010","article-title":"The ER chaperone and signaling regulator GRP78\/BiP as a monitor of endoplasmic reticulum stress","volume":"35","author":"Lee","year":"2005","journal-title":"Methods"},{"key":"10.1016\/j.jconrel.2019.05.026_bb0190","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1091\/mbc.10.11.3787","article-title":"Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress","volume":"10","author":"Haze","year":"1999","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.jconrel.2019.05.026_bb0195","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.biomaterials.2009.11.020","article-title":"The utilization of pathogen-like cellular trafficking by single chain block copolymer","volume":"31","author":"Sahay","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2019.05.026_bb0200","doi-asserted-by":"crossref","first-page":"6772","DOI":"10.1093\/emboj\/20.23.6772","article-title":"Calreticulin and calnexin in the endoplasmic reticulum are important for phagocytosis","volume":"20","author":"M\u00fcller-Taubenberger","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0205","doi-asserted-by":"crossref","first-page":"37621","DOI":"10.1074\/jbc.C112.403006","article-title":"Glycosyltransferase-specific Golgi-targeting mechanisms","volume":"287","author":"Petrosyan","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0210","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.bbamcr.2005.03.002","article-title":"Golgi structure in stress sensing and apoptosis","volume":"1744","author":"Hicks","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2019.05.026_bb0215","doi-asserted-by":"crossref","DOI":"10.1038\/srep17127","article-title":"Downregulation of the small GTPase SAR1A: a key event underlying alcohol-induced Golgi fragmentation in hepatocytes","volume":"5","author":"Petrosyan","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0220","doi-asserted-by":"crossref","DOI":"10.1038\/srep31962","article-title":"The role of Rab6a and phosphorylation of non-muscle myosin IIA tailpiece in alcohol-induced Golgi disorganization","volume":"6","author":"Petrosyan","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0225","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.2215\/CJN.12231212","article-title":"Kidney disease and multiple myeloma","volume":"8","author":"Heher","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0230","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrc2981","article-title":"Regulation of cancer cell metabolism","volume":"11","author":"Cairns","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2019.05.026_bb0235","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrc3038","article-title":"Otto Warburg's contributions to current concepts of cancer metabolism","volume":"11","author":"Koppenol","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2019.05.026_bb0240","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-cellbio-092910-154237","article-title":"Aerobic glycolysis: meeting the metabolic requirements of cell proliferation","volume":"27","author":"Lunt","year":"2011","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0245","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1749-6632.2000.tb06199.x","article-title":"Glucose deprivation-induced oxidative stress in human tumor cells: a fundamental defect in metabolism?","volume":"899","author":"Spitz","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0250","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.1074\/jbc.273.9.5294","article-title":"Glucose deprivation-induced cytotoxicity and alterations in mitogen-activated protein kinase activation are mediated by oxidative stress in multidrug-resistant human breast carcinoma cells","volume":"273","author":"Lee","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0255","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0891-5849(98)00217-2","article-title":"Metabolic oxidative stress activates signal transduction and gene expression during glucose deprivation in human tumor cells","volume":"26","author":"Blackburn","year":"1999","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0260","doi-asserted-by":"crossref","first-page":"5881","DOI":"10.1158\/1078-0432.CCR-17-1151","article-title":"MUC1-mediated metabolic alterations regulate response to radiotherapy in pancreatic cancer","author":"Gunda","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0265","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ccell.2017.06.004","article-title":"MUC1 and HIF-1alpha signaling crosstalk induces anabolic glucose metabolism to impart gemcitabine resistance to pancreatic cancer","volume":"32","author":"Shukla","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2019.05.026_bb0270","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1158\/0008-5472.CAN-16-3062","article-title":"De novo lipid synthesis facilitates gemcitabine resistance through endoplasmic reticulum stress in pancreatic cancer","author":"Tadros","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0275","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1038\/onc.2011.137","article-title":"Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2","volume":"30","author":"Chen","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.jconrel.2019.05.026_bb0280","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1158\/1535-7163.MCT-07-0482","article-title":"Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth","volume":"7","author":"Clem","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0285","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15503","article-title":"The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition","volume":"8","author":"Goodwin","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0290","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ccr.2008.05.005","article-title":"Tumor cell metabolism: cancer's Achilles' heel","volume":"13","author":"Kroemer","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2019.05.026_bb0295","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.3892\/or.2013.2735","article-title":"Inhibition of LDH-A by oxamate induces G2\/M arrest, apoptosis and increases radiosensitivity in nasopharyngeal carcinoma cells","volume":"30","author":"Zhai","year":"2013","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0300","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.canlet.2014.09.003","article-title":"2-Deoxy-D-glucose targeting of glucose metabolism in cancer cells as a potential therapy","volume":"355","author":"Zhang","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0305","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1038\/ncomms4295","article-title":"Induction of mitochondrial dysfunction as a strategy for targeting tumour cells in metabolically compromised microenvironments","volume":"5","author":"Zhang","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0310","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1158\/0008-5472.CAN-14-3400","article-title":"Metabolic signature identifies novel targets for drug resistance in Multiple Myeloma","author":"Maiso","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0315","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.freeradbiomed.2015.09.023","article-title":"Glutathione\u2013linking cell proliferation to oxidative stress","volume":"89","author":"Diaz-Vivancos","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0320","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.3892\/ol.2012.931","article-title":"Redox status expressed as GSH: GSSG ratio as a marker for oxidative stress in paediatric tumour patients","volume":"4","author":"Zitka","year":"2012","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0325","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/leu.2015.190","article-title":"Mitochondrial thioredoxin reductase regulates major cytotoxicity pathways of proteasome inhibitors in multiple myeloma cells","volume":"30","author":"Fink","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.jconrel.2019.05.026_bb0330","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.phrs.2016.01.029","article-title":"Oxidative stress and proteasome inhibitors in multiple myeloma","volume":"105","author":"Lipchick","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0335","doi-asserted-by":"crossref","first-page":"8382","DOI":"10.4049\/jimmunol.181.12.8382","article-title":"Transduction with the antioxidant enzyme catalase protects human T cells against oxidative stress","volume":"181","author":"Ando","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0340","doi-asserted-by":"crossref","first-page":"29667","DOI":"10.1074\/jbc.M301292200","article-title":"Catalase activity is regulated by c-Abl and Arg in the oxidative stress response","volume":"278","author":"Cao","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0345","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1128\/MCB.00544-08","article-title":"Glutathione peroxidase 3 mediates the antioxidant effect of peroxisome proliferator-activated receptor \u03b3 in human skeletal muscle cells","volume":"29","author":"Chung","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0350","doi-asserted-by":"crossref","first-page":"18121","DOI":"10.1073\/pnas.1009700107","article-title":"NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis","author":"Zhang","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0355","first-page":"2922","article-title":"The expanding role of mitochondria in apoptosis","volume":"15","author":"Wang","year":"2001","journal-title":"Genes Dev."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0360","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nrc2714","article-title":"Environment-mediated drug resistance: a major contributor to minimal residual disease","volume":"9","author":"Meads","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2019.05.026_bb0365","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1182\/blood.V87.3.1104.bloodjournal8731104","article-title":"Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF-kappa B","volume":"87","author":"Chauhan","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2019.05.026_bb0370","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.bbrc.2003.11.120","article-title":"Establishment of a new model of human multiple myeloma using NOD\/SCID\/\u03b3 c null (NOG) mice","volume":"313","author":"Miyakawa","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0375","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1021\/acs.molpharmaceut.5b00958","article-title":"SPECT\/CT imaging of pluronic nanocarriers with varying poly (ethylene oxide) block length and aggregation State","volume":"13","author":"Arranja","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0380","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jconrel.2004.09.002","article-title":"Distribution kinetics of a micelle-forming block copolymer Pluronic P85","volume":"100","author":"Batrakova","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2019.05.026_bb0385","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1007\/s11095-006-9104-4","article-title":"A review of poloxamer 407 pharmaceutical and pharmacological characteristics","volume":"23","author":"Dumortier","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0390","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jconrel.2008.04.013","article-title":"Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers","volume":"130","author":"Batrakova","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2019.05.026_bb0395","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/nm.2424","article-title":"Vascular anastomosis using controlled phase transitions in poloxamer gels","volume":"17","author":"Chang","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0400","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1021\/mp500298q","article-title":"Pluronics and MDR reversal: an update","volume":"11","author":"Alakhova","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0405","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jconrel.2005.03.019","article-title":"Pluronic block copolymers alter apoptotic signal transduction of doxorubicin in drug-resistant cancer cells","volume":"105","author":"Minko","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2019.05.026_bb0410","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1023\/A:1018942823676","article-title":"Fundamental relationships between the composition of pluronic block copolymers and their hypersensitization effect in MDR cancer cells","volume":"16","author":"Batrakova","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0415","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/leu.2011.256","article-title":"Impaired bortezomib binding to mutant beta5 subunit of the proteasome is the underlying basis for bortezomib resistance in leukemia cells","volume":"26","author":"Franke","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.jconrel.2019.05.026_bb0420","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/2050-7771-1-13","article-title":"The resistance mechanisms of proteasome inhibitor bortezomib","volume":"1","author":"Lu","year":"2013","journal-title":"Biomark Res."},{"key":"10.1016\/j.jconrel.2019.05.026_bb0425","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1182\/blood.V81.2.490.490","article-title":"P-glycoprotein expression in human plasma cell myeloma: correlation with prior chemotherapy","volume":"81","author":"Grogan","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2019.05.026_bb0430","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1200\/JCO.1994.12.1.115","article-title":"MDR-1 expression and response to vincristine, doxorubicin, and dexamethasone chemotherapy in multiple myeloma refractory to alkylating agents","volume":"12","author":"Cornelissen","year":"1994","journal-title":"J. Clin. Oncol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365919302743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365919302743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:40:17Z","timestamp":1759160417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365919302743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":86,"alternative-id":["S0168365919302743"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2019.05.026","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pluronic block copolymers enhance the anti-myeloma activity of proteasome inhibitors","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2019.05.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}